1,319
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Structural elucidation and evaluation of toxicity and antitumor activity of cardiac glycosides isolated from Leptadenia pyrotechnica

, &
Pages 826-834 | Received 22 Jan 2008, Accepted 19 May 2008, Published online: 27 Aug 2009
 

Abstract

Investigation of the chemical constituents of Leptadenia pyrotechnica (Forsk.) Decne (Asclepiadaceae) led to the isolation of three cardiac glycosides; 14,19-dihydroxycard-20 (22)-enolide-3-O-[β-d-glucopyranosyl-β-d-digitoxoside] C-I, 14,19-dihydroxycard-20 (22)-enolide-3-O-[β-d-glucopyranosyl-β-d-glucopyranoside] C-II and 14,19-dihydroxycard-20 (22)-enolide-3-O-β-d-digitoxoside C-III. The isolation and identification of these compounds were carried out using rotation locular counter current chromatography (RLCCC), high performance liquid chromatography (HPLC). The structures of the isolated compounds were established by fast-atom bombardment (FAB) and electrospray ionization (ESI) mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopic analysis. The acute toxicity studies of the cardiac glycosides and total alcohol extracts were examined by brine shrimp. Their lethal concentration 50 (LC50) were 18.84 and 11.89 ppm, respectively. The antitumor activity potato disk assays of the cardiac glycosides and total alcohol extracts had shown good activity − 30.8% and 49.3%, respectively.

Acknowledgements

AMYM is grateful to the Egyptian Ministry of higher Education, and the Environmental Chemistry and Toxicology Laboratory, Texas Southern University, Houston, for the Fellowship it has provided her with to undertake this work.

Declaration of interest: This work was supported by RCMI grant number R003045-17A and NASA/URC grant number NCC 9.165. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.